Navoximod Uses, Dosage, Side Effects and more
Navoximod is under investigation in clinical trial NCT02048709 (Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid Tumors).
| Trade Name | Navoximod |
| Generic | Navoximod |
| Navoximod Other Names | Navoximod |
| Type | |
| Formula | C18H21FN2O2 |
| Weight | Average: 316.376 Monoisotopic: 316.158706087 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
